BLISSGVS Share Price Target 2030

CAGR-based price projection for Bliss GVS Pharma Limited (BLISSGVS) targeting 2030, derived from official NSE exchange closing prices.

Bear Case (41.4% CAGR)
Rs 2,108
2030 Target
Base Case (103.5% CAGR)
Rs 9,048
2030 Target
Bull Case (408.6% CAGR)
Rs 352,686
2030 Target

Current Market Snapshot

CMP: Rs 527.10
52W High: Rs 539.60
52W Low: Rs 253.64
1Y CAGR: 314.3%
3Y CAGR: 103.5%

Year-by-Year Price Projection

YearBear CaseBase CaseBull Case
2027 Rs 745 Rs 1,073 Rs 2,681
2028 Rs 1,054 Rs 2,184 Rs 13,635
2029 Rs 1,491 Rs 4,445 Rs 69,345
2030 Rs 2,108 Rs 9,048 Rs 352,686

Other BLISSGVS Price Targets

2025 2026 2027 2028 2035 2040 2050

Frequently Asked Questions

What is the BLISSGVS share price target for 2030?

Based on historical growth analysis, the BLISSGVS share price target for 2030 ranges from Rs 2,108 (conservative) to Rs 9,048 (base case) to Rs 352,686 (optimistic). These projections are based on trailing CAGR and should not be treated as guaranteed outcomes.

What is the current share price of BLISSGVS?

The current market price of BLISSGVS (Bliss GVS Pharma Limited) is Rs 527.10. The 52-week high is Rs 539.60 and 52-week low is Rs 253.64.

Is BLISSGVS a good stock to buy for the long term?

Long-term investment decisions depend on individual risk tolerance, financial goals, and portfolio diversification. Examine the company's fundamentals, debt-to-equity ratio, promoter holding, and competitive positioning within its sector. BrokerLens provides data-driven analysis; consult a SEBI-registered financial advisor before investing.

What methodology does BrokerLens use for BLISSGVS price targets?

BrokerLens computes price targets using historical Compound Annual Growth Rate (CAGR) derived from official NSE closing prices. Three scenarios are modeled: Bear (conservative at 41.4% CAGR), Base (103.5% CAGR), and Bull (optimistic at 408.6% CAGR). These are statistical projections, not guaranteed forecasts.

Disclaimer: Share price targets on BrokerLens are statistical CAGR projections based on historical NSE closing prices. They are NOT guaranteed outcomes, investment advice, or analyst recommendations. Past performance does not guarantee future results. Consult a SEBI-registered investment advisor before making investment decisions. Mutual fund and equity investments are subject to market risks.